Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-18 5:16 pm Purchase | 2023-08-16 | 13D | Taysha Gene Therapies, Inc. TSHA | Astellas Pharma Inc. | 7,266,342 3.890% | 7,266,342 (New Position) | Filing History |
| 2023-02-09 12:39 pm Sale | 2023-02-09 | 13G | Taysha Gene Therapies, Inc. TSHA | FMR LLC | 3,204,922 5.132% | -69,635 (-2.13%) | Filing History |
| 2022-11-10 11:55 am Sale | 2022-11-09 | 13G | Taysha Gene Therapies, Inc. TSHA | FMR LLC | 3,274,557 5.951% | -1,005,937 (-23.50%) | Filing History |
| 2022-11-02 4:02 pm Purchase | 2022-10-31 | 13D | Taysha Gene Therapies, Inc. TSHA | Manning Paul B | 6,989,861 11.200% | 1,694,554 (+32.00%) | Filing History |
| 2022-10-31 4:02 pm Purchase | 2022-10-21 | 13D | Taysha Gene Therapies, Inc. TSHA | Audentes Therapeutics Inc. BOLD | 7,266,342 11.600% | 7,266,342 (New Position) | Filing History |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | Taysha Gene Therapies, Inc. TSHA | BlackRock Inc. BLK | 1,046,490 2.600% | -1,986,473 (-65.50%) | Filing History |
| 2022-02-09 10:01 am Sale | 2022-02-08 | 13G | Taysha Gene Therapies, Inc. TSHA | FMR LLC | 4,280,494 11.125% | -1,383,721 (-24.43%) | Filing History |
| 2022-02-07 4:41 pm Purchase | 2021-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | BlackRock Inc. BLK | 3,032,963 7.900% | 803,147 (+36.02%) | Filing History |
| 2021-09-23 6:56 pm Sale | 2021-09-22 | 13G | Taysha Gene Therapies, Inc. TSHA | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 1,156,255 3.010% | -1,022,745 (-46.94%) | Filing History |
| 2021-02-16 1:35 pm Purchase | 2020-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 2,179,000 5.770% | 2,179,000 (New Position) | Filing History |
| 2021-02-08 10:33 am Purchase | 2021-02-05 | 13G | Taysha Gene Therapies, Inc. TSHA | FMR LLC | 5,664,215 14.999% | 1,456,641 (+34.62%) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | BlackRock Inc. BLK | 2,229,816 5.900% | 2,229,816 (New Position) | Filing History |
| 2020-10-13 10:35 am Purchase | 2020-10-12 | 13G | Taysha Gene Therapies, Inc. TSHA | FMR LLC | 4,207,574 11.374% | 4,207,574 (New Position) | Filing History |
| 2020-10-05 5:26 pm Purchase | 2020-09-23 | 13D | Taysha Gene Therapies, Inc. TSHA | Manning Paul B | 5,295,307 14.300% | 5,295,307 (New Position) | Filing History |
| 2020-10-05 4:58 pm Purchase | 2020-09-23 | 13D | Taysha Gene Therapies, Inc. TSHA | Session R.A. II | 9,430,582 25.500% | 9,430,582 (New Position) | Filing History |